Evidence map›Paper›PMID 42190195›Full record

ArticleDermatology practical & conceptual2026

Neutrophil Albumin Ratio, Platelet Albumin Ratio, and Certain Inflammatory Parameters in Acne Vulgaris.

Neşe Göçer Gürok, Zekiye Çatak

Abstract read
In one paragraph

Article in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neşe Göçer GürokDepartment of Dermatology, Fethi Sekin City Hospital, Elazig, Turkey.
Zekiye ÇatakDepartment of Medical Biochemistry, Fethi Sekin City Hospital, Elazig, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcne vulgaris is a prevalent, chronic inflammatory disease. Systemic inflammation may be evaluated with various biochemical and hematological markers.

objectivesThe present study was conducted to determine an easy-to-identify and low-cost disease activity marker. We investigated the neutrophil/albumin ratio (NAR), platelet/albumin ratio (PAR), C-reactive protein/albumin ratio (CAR), hemoglobin/albumin ratio (HAR), platelet/hemoglobin ratio (PHR), neutrophil/hemoglobin ratio (NHR), systemic immune response index (SIRI), and monocyte/high-density lipoprotein cholesterol ratio (MHR) in patients with moderate or severe acne vulgaris and the correlations between these markers and the disease.

methodsThe study was conducted on 50 moderate-to-severe acne vulgaris patients and 69 healthy controls. The patient and control groups were similar in age and sex. Patient and control group demographics and laboratory data were collected retrospectively from the patient files.

resultsIt was determined that albumin, HDL, and CRP levels, and CAR, NAR, PAR, MHR, SIRI, HAR, PHR, and NHR were similar in acne patients and the control group (P=0.672; P=0.265; P=0.318; P=0.303; P=0.991; P=0.096; P=0.972; P=0.325, P=0.337; P=0.051; P=0.057). Furthermore, specific hemogram parameters were compared between the patient and control groups, with no statistically significant difference determined (P>0.05). However, subgroup analysis by sex showed that female patients had higher HDL and HAR values, while male patients had higher albumin, PHR, NHR, and MHR levels (P<0.05).

conclusionNo statistically significant association was found between the evaluated systemic inflammation biomarkers and acne vulgaris. Nevertheless, sex-based differences in certain parameters among patients indicate possible sex-specific pathophysiological mechanisms. Prospective, large-scale studies are warranted to further investigate these findings and clarify their clinical implications.

Identifiers

PMID42190195
PMCPMC13211893

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.